DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹13,281 Cr | ₹11,984 Cr | ₹15,217 Cr | ₹11,853 Cr | ₹8,022 Cr |
What is the latest Net Current Assets ratio of DR REDDYS LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹13,281 Cr |
| Mar2025 | ₹11,984 Cr |
| Mar2024 | ₹15,217 Cr |
| Mar2023 | ₹11,853 Cr |
| Mar2022 | ₹8,022 Cr |
How is Net Current Assets of DR REDDYS LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,281 Cr | 10.82 | |
| Mar2025 | ₹11,984 Cr | -21.25 | |
| Mar2024 | ₹15,217 Cr | 28.38 | |
| Mar2023 | ₹11,853 Cr | 47.76 | |
| Mar2022 | ₹8,022 Cr | - | |
Compare Net Current Assets of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹103,982.8 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,509.0 Cr | 1.7% | 6.4% | 4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -7.6% |
-2.2% |
-5.8% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses